October 18, 2011
AURORA, Ontario, October 18, 2011 – Helix BioPharma Corp. (TSX, NYSE Amex, FSE: “HBP”), today announced that the
directors have received a shareholder requisition to call a meeting of shareholders to elect directors and set the number of directors to be elected at the meeting at seven (7). The shareholders making the requisition have proposed a slate which includes three (3) new directors and four (4) incumbent directors. These shareholders stated that they hold approximately 11.8% of Helix’s outstanding shares.